Maryam Honardoost
- Genetics top 5%
- Hepatology top 5%
-
- MicroRNA in disease regulation 9
- Cancer-related molecular mechanisms research 6
-
- Pituitary Gland Disorders and Treatments 4
- Thyroid Cancer Diagnosis and Treatment 4
-
- Circular RNAs in diseases 6
- RNA Interference and Gene Delivery 3
-
- COVID-19 Clinical Research Studies 4
- SARS-CoV-2 and COVID-19 Research 3
- Co-authors
- Mohammad E. KhamsehMasoud SoleimaniKatayoun AghajaniFereshteh JafariAmir AtashiMohammad Reza ZaliBabak NoorinayerPer M. Hellström
- Cited by
- GeneticsHepatologyCancer Research
- Journals
- Applied Biochemistry and Biotechnology (3 papers)Journal of Cellular Biochemistry (1 paper)Placenta (1 paper)
- Partner nations
- IranUnited KingdomUnited States
In The Last Decade
Maryam Honardoost
36 papers receiving 746 citations
Peers
Comparison fields: 5 of 91
- Genetics 238
- Hepatology 172
- Cancer Research 157
- Surgery 251
- Endocrinology, Diabetes and Metabolism 72
Countries citing papers authored by Maryam Honardoost
This map shows the geographic impact of Maryam Honardoost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maryam Honardoost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maryam Honardoost more than expected).
Fields of papers citing papers by Maryam Honardoost
This network shows the impact of papers produced by Maryam Honardoost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maryam Honardoost. The network helps show where Maryam Honardoost may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Maryam Honardoost, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 0 | |
| 6 | 2022 | 6 | |
| 7 | 2022 | 10 | |
| 8 | 2022 | 4 | |
| 9 | 2021 | 5 | |
| 10 | 2020 | 16 | |
| 11 | 2020 | 6 | |
| 12 | 2020 | 11 | |
| 13 | 2019 | 12 | |
| 14 | 2018 | 1 | |
| 15 | 2017 | 22 | |
| 16 | 2017 | 14 | |
| 17 | Molecular mechanism of insulin resistance | 2014 | 5 |
| 18 | 2014 | 35 | |
| 19 | Apoptosis: programmed cell death | 2013 | 2 |
| 20 | 2009 | 356 |
About Maryam Honardoost
Maryam Honardoost is a scholar working on Cancer Research, Endocrinology, Diabetes and Metabolism, Biological Psychiatry, Molecular Biology and Hepatology, having authored 41 papers that have together received 758 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (6 papers), COVID-19 Clinical Research Studies (4 papers), Pituitary Gland Disorders and Treatments (4 papers), Thyroid Cancer Diagnosis and Treatment (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Genetics (238 citations), Hepatology (172 citations), Cancer Research (157 citations), Surgery (251 citations) and Endocrinology, Diabetes and Metabolism (72 citations). Maryam Honardoost has collaborated with scholars based in Iran, United Kingdom and United States. Frequent co-authors include Mohammad E. Khamseh, Masoud Soleimani, Katayoun Aghajani, Fereshteh Jafari, Amir Atashi, Mohammad Reza Zali, Babak Noorinayer, Per M. Hellström, Pedram Kharaziha and Ehsan Arefian. Their work appears in journals such as Applied Biochemistry and Biotechnology, Journal of Cellular Biochemistry, Placenta, European Journal of Gastroenterology & Hepatology and Critical Reviews in Food Science and Nutrition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.